Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020

Jiaye Liu, Xuejiao Liao, Shen Qian, Jing Yuan, Fuxiang Wang, Yingxia Liu, Zhaoqin Wang, Fu-Sheng Wang, Lei Liu, Zheng Zhang, Jiaye Liu, Xuejiao Liao, Shen Qian, Jing Yuan, Fuxiang Wang, Yingxia Liu, Zhaoqin Wang, Fu-Sheng Wang, Lei Liu, Zheng Zhang

Abstract

Since early January 2020, after the outbreak of coronavirus infection in Wuhan, China, ≈365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily transmission is threatening residents in Shenzhen. Strategies to strengthen prevention and interruption of these transmissions should be urgently addressed.

Keywords: 2019 novel coronavirus; COVID-19; China; SARS-CoV-2; Shenzhen; community transmission; coronavirus; epidemiologic; respiratory infections; severe respiratory syndrome coronavirus 2; viruses.

Figures

Figure
Figure
Onset of illness timeline for the first 365 confirmed COVID-19 case-patients in Shenzhen, China. The decline in incidence after January 30, 2020, probably resulted from delays in diagnosis and laboratory confirmation. All cases in this curve were confirmed. Hospital-based surveillance began January 8, 2020, for patients with suspected cases, defined by having a history of travel to Wuhan within the past 14 days, fever, and radiographic evidence of viral pneumonitis. PCR confirmation began January 13, 2020, and subsequently expanded the criteria for patients with suspected cases, defined by having typical clinical manifestations of COVID-19 and excluding infection caused by type A and B influenza and respiratory syncytial virus, regardless of travel history. NCIP, novel coronavirus–infected pneumonia (now called COVID-19).

References

    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. NEJM. 2020. Jan 31 [cited 2020 Feb 7].
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020;395:497–506 [cited 2020 Feb 7].
    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. [cited 2020 Feb 7]. Lancet. 2020;395:507–13. 10.1016/S0140-6736(20)30211-7
    1. Wang DW, Hu B, Hu C. , Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020. Feb 7 [cited 2020 Feb 16].
    1. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. [cited 2020 Feb 7]. Lancet. 2020;395:514–23. 10.1016/S0140-6736(20)30154-9
    1. Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. [cited 2020 Feb 7]. World J Pediatr. 2020. 10.1007/s12519-020-00345-5
    1. Wang FS, Zhang C. What to do next to control the 2019-nCoV epidemic? [cited 2020 Feb 7]. Lancet. 2020;395:391–3. 10.1016/S0140-6736(20)30300-7

Source: PubMed

3
Abonneren